The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Open accessAbstract
The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8% to 12.8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 535
AETIOLOGY OF PARKINSON'S DISEASE
Calne, D., & Langston, J. W. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469
Kosaka, K., Yoshimura, M., Ikeda, K., & Budka, H. (1984) · PubMed · Cited by 401
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 351
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J., Eldridge, R., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.815 · Cited by 347
Duffy, P. E., & Tennyson, V. M. (1965) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196507000-00003 · Cited by 345
THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE
Gibb, W. R. G., & Lees, A. J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01147.x · Cited by 325
Self-citationEsophageal Lewy bodies associated with ganglion cell loss in achalasia
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90079-9 · Cited by 305
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · PubMed · Cited by 295
Dooling, E. C., Schoene, W. C., & Richardson, E. P. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490310072012 · Cited by 269
Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens
Goldman, J. E., Yen, S.-H. C., Chiu, F., & Peress, N. S. (1983) · Science · doi:10.1126/science.6308771 · Cited by 268
Parkinson's disease in a Scottish city.
Mutch, W. J., Dingwall-Fordyce, I., Downie, A. W., Paterson, J. G., & Roy, S. K. (1986) · BMJ · doi:10.1136/bmj.292.6519.534 · Cited by 255
Familial Amyotrophic Lateral Sclerosis
Hirano, A. (1967) · Archives of Neurology · doi:10.1001/archneur.1967.00470210008002 · Cited by 238
Lewy bodies in cerebral cortex. Report of three cases
Kosaka, K. (1978) · Acta Neuropathologica · doi:10.1007/bf00690978 · Cited by 232
Reversible Drug-Induced Parkinsonism
Rajput, A. H. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510220042009 · Cited by 145
The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and Man
Burns, R. S., Markey, S. P., Phillips, J. M., & Chiueh, C. C. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100046345 · Cited by 142
CONCENTRIC HYALINE INCLUSION BODY FORMATION IN MENTAL DISEASE ANALYSIS OF TWENTY-SEVEN CASES
Woodard, J. S. (1962) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196207000-00012 · Cited by 128
Bethlem, J., & Jager, W. A. D. H. (1960) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.74 · Cited by 102
Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects.
Yokochi, M., Narabayashi, H., Iizuka, R., & Nagatsu, T. (1984) · PubMed · Cited by 87
Recent Advances in Parkinson’s Disease
Iams, J. F. (1972) · Physical Therapy · doi:10.1093/ptj/52.10.1117a · Cited by 75
Dickson, D. W., Kress, Y., Crowe, A., & Yen, S. H. (1985) · PubMed Central · Cited by 71
The Neurobiology of Dopamine Systems
&NA;, &. (1987) · International Clinical Psychopharmacology · doi:10.1097/00004850-198707000-00017 · Cited by 68
Immunohistochemical localization of neurofilament protein in neuronal degenerations
Nakazato, Y., Sasaki, A., Hirato, J., & Ishida, Y. (1984) · Acta Neuropathologica · doi:10.1007/bf00695603 · Cited by 66
Neuropathology of the locus ceruleus: a semi-quantitative study
Tomonaga, M. (1983) · Journal of Neurology · doi:10.1007/bf00313699 · Cited by 61
The rostral mesencephalon in Parkinson's disease and Alzheimer's disease
Hunter, S. (1985) · Acta Neuropathologica · doi:10.1007/bf00688956 · Cited by 56
Smoking and Parkinson's Disease
Golbe, L. I. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520080022014 · Cited by 56
Agamanolis, D. P., & Greenstein, J. I. (1979) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197909000-00003 · Cited by 55
Sachdev, H. S., Forno, L. S., & Kane, C. A. (1982) · Neurology · doi:10.1212/wnl.32.2.192 · Cited by 50
Relationship of aging to Parkinson's disease.
Koller, W. C., O'Hara, R., Weiner, W. J., Lang, A. E., Nutt, J. G., Agid, Y., Bonnet, A. M., & Jankovic, J. J. (1987) · PubMed · Cited by 48
Nerve Cell Death in Degenerative Diseases of the Central Nervous System: Clinical Aspects
Agid, Y., & Blin, J. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513422.ch2 · Cited by 44
Aluminum-induced neurofibrillary changes in axons and dendrites
Wı́sniewski, H. M., Shek, J. W., Gruca, S., & Sturman, J. A. (1984) · Acta Neuropathologica · doi:10.1007/bf00685244 · Cited by 44
The low concordance rate for Parkinson's disease in twins
Eldridge, R., & Ince, S. E. (1984) · Neurology · doi:10.1212/wnl.34.10.1354 · Cited by 41
ÜBER ZELLEIB-VERÄNDERUNGEN IM NUCLEUS COERULEUS BEI PARKINSON-SYMPTOMEN
Beheim-Schwarzbach, D. (1952) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195212000-00017 · Cited by 33
Neuronal Filaments in Alzheimer's, Pick's, and Parkinson's Diseases
Kahn, J., Anderton, B. H., Gibb, W. R. G., Lees, A. J., Wells, F. R., & MARSDEN, C. D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508223130817 · Cited by 24
Self-citationForno, L. S., Strefling, A. M., Sternberger, L. A., Sternberger, N. H., & Eng, L. F. (1983) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198305000-00118 · Cited by 20
[FAMILIAL CEREBELLAR ATROPHY WITH ASSOCIATION OF NIGERIAN AND SPINAL LESIONS].
Sigwald, J., Lapresle, J., Raverdy, P., & de Recondo, J. (1964) · PubMed · Cited by 20
Hirai, S. (1968) · PubMed · Cited by 16
Liu, H. M., Ovadia, L., & Farr, L. (1983) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198305000-00120 · Cited by 2
Research works printed but not linked: 7
- Gibb WRG. The Lewy body and Parkinson's disease. In: Clifford Rose F, ed. Parkinson's Disease: Clinical and Experimental Advances. London: John Libbey and Co, 1987:3-11.
- Oppenheimer D. Neuropathology of progressive autonomic failure. In: Bannister R, ed. Autonomic failure. Oxford University Press, London, 1983:267-83.
- Sigwald J, Lapresle J, Raverdy P, Recondo NJ. Atrophie cerebelleuse familiale avec association de lesions nigeriennes et spinales. Presse Med 1964;72:557-62.
- Vogt C, Vogt 0. Erkrankungen der GroBhirnrinde im Lichte der Topistik, Pathoklise und Pathoarchitektonik. J Psychol Neurol 1922;28:1-171.
- Hamada S, Ishii T. The Lewy body in the brain of the aged. Adv Neurol Sci 1963;7:184-6.
- Hirai S. Ageing of the substantia nigra. Adv Neurol Sci 1968;12:845-9.
- Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476.
Cited by
Sorted by citations
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Self-citationMDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Metadata
- Authors
- Gibb, W. R., & Lees, A. J.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1988-06-01
- Volume
- 51
- Issue
- 6
- Pages
- 745-752
- ISSN
- 0022-3050 (ISSN-L)
- PMC
- PMC1033142
- OpenAlex
- W2132881915
- Semantic Scholar
- 354cd1cf28ad23a8038bb3c576ff7791b3c74543
- Cited by
- 3,481
- References
- 39
- Citations by year
- 2026: 78 · 2025: 130 · 2024: 152 · 2023: 143 · 2022: 131 · 2021: 158 · 2020: 164 · 2019: 152 · 2018: 138 · 2017: 156 · 2016: 163 · 2015: 115 · 2014: 149 · 2013: 123 · 2012: 138
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Lewy bodies, Parkinson's disease, pathogenesis, neurofilaments, substantia nigra, incidental Lewy body disease, age-related prevalence, neuronal loss
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Brain, Brain Damage, Chronic, Inclusion Bodies, Child, Humans, Middle Aged, Nerve Degeneration, Parkinson Disease, Substantia Nigra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review